1-5 of 5
Michelino De Laurentiis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial

Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K. Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi El-Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debu Tripathy
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 851–859.
https://doi.org/10.1158/1078-0432.CCR-21-3032
Published: 01 March 2022
View article titled, Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR<sup>+</sup>/HER2<sup>−</sup> Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Open the PDF for Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR<sup>+</sup>/HER2<sup>−</sup> Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Sherko Kuemmel, Mario Campone, Delphine Loirat, Rafael Lopez Lopez, J. Thaddeus Beck, Michelino De Laurentiis, Seock-Ah Im, Sung-Bae Kim, Ava Kwong, Guenther G. Steger, Esther Zamora Adelantado, Francois P. Duhoux, Richard Greil, Irene Kuter, Yen-Shen Lu, Ariadna Tibau, Mustafa Özgüroğlu, Christian W. Scholz, Christian F. Singer, Estela Vega, Pauline Wimberger, Claudio Zamagni, Xuan-Mai Couillebault, Liqiong Fan, Nelson Guerreiro, Jennifer Mataraza, Janna Sand-Dejmek, Arlene Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (1): 106–115.
https://doi.org/10.1158/1078-0432.CCR-20-3955
Published: 05 January 2022
View article titled, A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Open the PDF for A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Twenty-year Results of the Naples GUN Randomized Trial: Predictive Factors of Adjuvant Tamoxifen Efficacy in Early Breast Cancer

Sabino De Placido, Michelino De Laurentiis, Chiara Carlomagno, Ciro Gallo, Franco Perrone, Stefano Pepe, Angela Ruggiero, Alfredo Marinelli, Clorindo Pagliarulo, Luigi Panico, Guido Pettinato, Giuseppe Petrella, Angelo Raffaele Bianco
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (3): 1039–1046.
Published: 01 March 2003
View article titled, Twenty-year Results of the Naples GUN Randomized Trial: <subtitle>Predictive Factors of Adjuvant Tamoxifen Efficacy in Early Breast Cancer</subtitle>
Open the PDF for Twenty-year Results of the Naples GUN Randomized Trial: <subtitle>Predictive Factors of Adjuvant Tamoxifen Efficacy in Early Breast Cancer</subtitle> in another window
Journal Articles

A Prognostic Model That Makes Quantitative Estimates of Probability of Relapse for Breast Cancer Patients

Michelino De Laurentiis, Sabino De Placido, Angelo R. Bianco, Gary M. Clark, Peter M. Ravdin
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4133–4139.
Published: 01 December 1999
View article titled, A Prognostic Model That Makes Quantitative Estimates of Probability of Relapse for Breast Cancer Patients
Open the PDF for A Prognostic Model That Makes Quantitative Estimates of Probability of Relapse for Breast Cancer Patients in another window
Journal Articles

Measurement of Neovascularization Is an Independent Prognosticator of Survival in Node-negative Breast Cancer Patients with Long-Term Follow-Up

Sabino De Placido, Chiara Carlomagno, Fortunato Ciardiello, Michelino De Laurentiis, Stefano Pepe, Angela Ruggiero, Giampaolo Tortora, Luigi Panico, Antonio D’Antonio, Guido Pettinato, Giuseppe Petrella, A. Raffaele Bianco
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 2854–2859.
Published: 01 October 1999
View article titled, Measurement of Neovascularization Is an Independent Prognosticator of Survival in Node-negative Breast Cancer Patients with Long-Term Follow-Up
Open the PDF for Measurement of Neovascularization Is an Independent Prognosticator of Survival in Node-negative Breast Cancer Patients with Long-Term Follow-Up in another window